Search Results - "Makiko, Urabe"

Refine Results
  1. 1

    Mcl-1 expression is a predictive marker of response to gemcitabine plus nab-paclitaxel for metastatic pancreatic cancer by Urabe, Makiko, Ikezawa, Kenji, Seiki, Yusuke, Watsuji, Ko, Kawamoto, Yasuharu, Hirao, Takeru, Kai, Yugo, Takada, Ryoji, Yamai, Takuo, Mukai, Kaori, Nakabori, Tasuku, Uehara, Hiroyuki, Nagata, Shigenori, Ohkawa, Kazuyoshi

    Published in Scientific reports (20-09-2024)
    “…Antiapoptotic protein, including Mcl-1, expression is frequently observed in pancreatic cancer. Gemcitabine plus nabpaclitaxel (GnP) is the standard…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer by Takada, Ryoji, Ikezawa, Kenji, Yamai, Takuo, Watsuji, Ko, Seiki, Yusuke, Kawamoto, Yasuharu, Hirao, Takeru, Higashi, Sena, Urabe, Makiko, Kai, Yugo, Nakabori, Tasuku, Uehara, Hiroyuki, Kotani, Michiyo, Yagi, Toshinari, Kimura, Miho, Nozaki, Keisuke, Takagi, Mari, Ohkawa, Kazuyoshi

    Published in BMC cancer (31-07-2023)
    “…Nanoliposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU)/levo-leucovorin (Levo-LV) was approved for unresectable pancreatic cancer (UR-PC) in March 2020…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Portal Vein Aneurysm in a Patient with Cirrhosis Type C Controlled by Direct-Acting Antiviral Treatment by Higashi, Sena, Nakabori, Tasuku, Mukai, Kaori, Seiki, Yusuke, Watsuji, Ko, Hirao, Takeru, Kawamoto, Yasuharu, Urabe, Makiko, Kai, Yugo, Takada, Ryoji, Yamai, Takuo, Ikezawa, Kenji, Uehara, Hiroyuki, Ohkawa, Kazuyoshi

    Published in Case reports in gastroenterology (01-01-2024)
    “…Abstract Introduction: Portal vein aneurysm (PVA) is a rare saccular or fusiform portal vein dilatation. The management and optimal treatment of PVA remain…”
    Get full text
    Journal Article
  11. 11

    Feasibility of immunotherapy in cancer patients with persistent or past hepatitis B or C virus infection by Nakabori, Tasuku, Abe, Yutaro, Higashi, Sena, Hirao, Takeru, Kawamoto, Yasuharu, Maeda, Shingo, Daiku, Kazuma, Urabe, Makiko, Kai, Yugo, Takada, Ryoji, Yamai, Takuo, Ikezawa, Kenji, Uehara, Hiroyuki, Ohkawa, Kazuyoshi

    Published in JGH open (01-05-2022)
    “…Background and Aim Immune checkpoint inhibitors (ICIs) can cause immune‐related adverse events in the liver. The risk of exacerbating liver injury is of…”
    Get full text
    Journal Article
  12. 12

    A case of multiple myeloma with pancreatic involvement diagnosed via endoscopic ultrasound‐guided fine needle aspiration by Hiraga, Erika, Yamai, Takuo, Ikezawa, Kenji, Kawamoto, Yasuharu, Hirao, Takeru, Higashi, Sena, Urabe, Makiko, Kai, Yugo, Takada, Ryoji, Nakabori, Tasuku, Uehara, Hiroyuki, Ryu, Ayumi, Yuda, Sayako, Honma, Keichiro, Ohkawa, Kazuyoshi

    Published in Clinical case reports (01-04-2023)
    “…This report highlights the importance of considering multiple myeloma in the differential diagnosis of a pancreatic tumor with bone lesions. sampling not only…”
    Get full text
    Journal Article
  13. 13

    Activation of p53 After Irradiation Impairs the Regenerative Capacity of the Mouse Liver by Urabe, Makiko, Hikita, Hayato, Saito, Yoshinobu, Kudo, Shinnosuke, Fukumoto, Kenji, Mizutani, Naoki, Myojin, Yuta, Doi, Akira, Sato, Katsuhiko, Sakane, Sadatsugu, Makino, Yuki, Kodama, Takahiro, Sakamori, Ryotaro, Tatsumi, Tomohide, Takehara, Tetsuo

    Published in Hepatology communications (01-02-2022)
    “…Radiation therapy is one of the treatment methods for hepatocellular carcinoma. However, radiation tolerance of the liver is low, and the detailed effect of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment by Ikezawa, Kenji, Urabe, Makiko, Kai, Yugo, Takada, Ryoji, Akita, Hirofumi, Nagata, Shigenori, Ohkawa, Kazuyoshi

    Published in Japanese journal of clinical oncology (09-03-2024)
    “…Abstract Pancreatic acinar cell carcinoma is a rare form (0.2–4.3%) of pancreatic neoplasm with unique clinical and molecular characteristics, which largely…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Risk Factors for Pancreatic Cancer and the Necessity of Long-Term Surveillance in Patients With Pancreatic Cystic Lesions by Yoshioka, Teppei, Shigekawa, Minoru, Ikezawa, Kenji, Tamura, Takeshi, Sato, Katsuhiko, Urabe, Makiko, Sueyoshi, Hironari, Yamai, Takuo, Suda, Takahiro, Sakamori, Ryotaro, Tatsumi, Tomohide, Takehara, Tetsuo

    Published in Pancreas (01-04-2020)
    “…Pancreatic cystic lesions (PCLs) are a risk factor for pancreatic cancer (PC). Which PCLs should be surveilled and necessity of long-term observation are still…”
    Get full text
    Journal Article
  20. 20